Phillip A. Sharp - Feb 9, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role: Director
Signature: By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp
Stock symbol: ALNY
Transactions as of: Feb 9, 2022
Transactions value $: -$4,160,100
Form type: 4
Date filed: 2/11/2022, 03:04 PM
Previous filing: Jul 19, 2021
Next filing: May 20, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALNY	Common Stock	Options Exercise	$340K	+30K		$11.33^*	30K	Feb 9, 2022	Direct	F1
transaction	ALNY	Common Stock	Sale	-$4.5M	-30K	-100%	$150.00	0	Feb 9, 2022	Direct	F1
holding	ALNY	Common Stock						267K	Feb 9, 2022	by Trust	F2

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALNY	Stock Option (right to buy)	Options Exercise	$0	-30K	-100%	$0.00^*	0	Feb 9, 2022	Common Stock	30K	$11.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 30,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.
F2	Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.